Across 367 real-world illness episodes, 81.6% reported meaningful improvement within 3 days and 86.1% avoided in-person medical care.
We surveyed 506 verified purchasers of The Wellness Company’s Medical Emergency Kit and analyzed 367 real-world illness episodes reported by respondents. Our objective was to characterize utilization patterns, self-reported outcomes, healthcare utilization, and safety in real-world settings.

What Were People Using the Kits For?
Among the 367 reported illness episodes:
- Respiratory illnesses: 59.4% (218 episodes)
- Urinary symptoms: 15.0% (55 episodes)
- Gastrointestinal illnesses: 6.3% (23 episodes)
- Dental issues: 5.7% (21 episodes)
- Skin or soft tissue concerns: 4.1% (15 episodes)
- Injuries or wounds: 1.6% (6 episodes)
- Allergic reaction symptoms: 0.5% (2 episodes)
- Other: 7.4% (27 episodes)

Most episodes occurred at home (78.2%), while 20.7% occurred during domestic or international travel or in remote settings. Overall, 31.1% of users reported using their kit at least once while traveling or away from conventional healthcare access.
Outcomes
Among 333 intended-use illness episodes:
- 81.6% (95% CI, 77.1–85.4) reported meaningful improvement within 3 days
- 36.7% (95% CI, 31.7–42.1) reported meaningful improvement within 24 hours
- 86.1% (95% CI, 82.0–89.4) avoided hospital, urgent care, or clinic visitation
- 51.8% (95% CI, 46.4–57.1) reported a reduced need for urgent care or the ER
- 95.8% (95% CI, 93.0–97.5) reported overall benefit
- Side effects occurred in just 2.4% (95% CI, 1.2–4.7) of cases and were all mild
Notably, 79.0% of respondents did not contact a clinician at any point during their illness episode, and only 5.4% (95% CI, 3.5–8.2) reported any urgent care visit, emergency department visit, or hospitalization within 7 days of kit use.
These findings indicate that pre-prescribed emergency medication kits represent a practical model for improving timely access to treatment and guided self-management of common acute illnesses when conventional healthcare access is limited, delayed, or inconvenient. Large prospective trials are now warranted.
LINK TO OTHER DETAILS: https://open.substack.com/pub/petermcculloughmd/p/breaking-first-ever-real-world-study?r=1dbkwf&utm_medium=ios
